Key points are not available for this paper at this time.
Not just another meeting, the conference of the American Association for the Treatment of Opioid Dependence (AATOD) held last week in Las Vegas was a coming together of the minds of the only providers in the country who have ever treated patients with opioid use disorder (OUD) with methadone. And it was clearly time for this meeting to be a positive one, focused on the importance of comprehensive care to patients. ADAW has written about the challenge to opioid treatment programs (OTPs) posed by the Modernizing Opioid Treatment Access Act (MOTAA) many times (see https://onlinelibrary.wiley.com/doi/10.1002/adaw.34028 , https://onlinelibrary.wiley.com/doi/10.1002/adaw.34003 , https://onlinelibrary.wiley.com/doi/10.1002/adaw.33951 ), and one key advocacy session on May 21 presented the case very clearly.
Alison Knopf (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: